In addition to the prognostic value of CCM3 in osteosarcoma, overexpression of CCM3 decreased cell susceptibility to apoptosis and stimulated tumourigenic phenotypes by activating the EMT pathway, whereas cells with reduced levels of CCM3 exhibited the opposite effects [93]. Here, PDCD10 is linked to osteosarcoma.